Advanced Treatment for Neuroendocrine Tumors
At BAMF Health, we bring together advanced imaging, cutting-edge therapy, and world-class expertise to change what’s possible for those with neuroendocrine tumors.
Whether you’ve just been diagnosed and want a second opinion or are exploring options beyond traditional treatments, we’re here to help you live longer and live better.
Let’s take the next step together.
Experts in Treating Neuroendocrine Cancer
At BAMF Health, we don’t just treat neuroendocrine tumors — we redefine how cancer is managed. We are the global leader in Theranostics, the combination of advanced molecular imaging and targeted radiopharmaceutical therapy. We provide precise diagnosis, personalized treatment, advanced clinical trials, and compassionate care all under one roof.
You deserve more than just hope. You deserve precision, comfort, and an expert care team fully dedicated to your journey.
What makes us different
- Expertise – our providers have decades of experience in radiation oncology and Theranostics
- Comprehensive care – from diagnosis to therapy and follow-up, guided by the same expert team
- Advanced technology – including the most advanced PET/CT scanner ever built, Michigan’s only PET/MR, and SPECT/CT imaging
-
Access to clinical trials – offering novel radiopharmaceutical imaging and therapy trials before they are widely available
Ella's Story
Most Advanced PET/CT Scans
At BAMF Health, you have access to the most advanced PET scanner ever built. It not only finds cancer that traditional scanners miss, but also scans in less than 5 minutes.
This targeted imaging uses a radioactive tracer to identify a unique protein on neuroendocrine tumor cells called a somatostatin receptor. Once the tracer binds to the receptors, it lights up, revealing the exact location of the cancer down to the millimeter.
Ask your doctor to order your PET scan at BAMF Health and you’ll:
- Get in faster
- Get scanned quicker
- Get results sooner
Targeted Radiopharmaceutical Therapy
BAMF Health offers the PSMA-targeted radiopharmaceutical therapy called Lutathera (lutetium lu 177 dotatate). This revolutionary treatment delivers radiation directly to cancer cells while sparing healthy tissues. Most of our patients experience little to no side effects and can continue doing the things they love throughout their treatment journey.
Our facility was specifically designed to deliver these types of treatments. Each space you encounter is curated for administering radiopharmaceuticals efficiently, safely, and comfortably. It’s what we do best, and it shows.
Personalized Treatment with SPECT/CT
We follow a unique, beneficial treatment protocol using the GE StarGuide SPECT/CT scanner. Within 24 hours of every treatment cycle, patients return to BAMF Health for a SPECT/CT scan. This scan shows us exactly where the treatment is in your body and how hard it’s working. That same day, we review and compare your scan results to assess the changes throughout your treatment course. It’s true precision medicine in action.
The SPECT/CT Difference
-
"It's remarkable! You could see where the cancer was after my first treatment. The cancer spots lit up. I can't wait for my next scan."
Ella -
"You see the magic on the screen the next day, and that's when you know things are really happening. It's like being on the Starship Enterprise!"
Michael -
"It's real-time monitoring of what's going on with the cancer. It's great to look at the scans side-by-side and compare to previous scans."
Mark
What to Expect as a Patient
- Meet with our expert, Dr. Brandon Mancini, for a one-on-one consultation to discuss your health history, previous scans, and prior treatments
- Schedule a PET scan at BAMF Health, if you haven’t had one already
- Connect with a nurse navigator to receive education and a personalized treatment plan tailored to your needs
- Treatment is delivered at the BAMF Health Molecular Therapy Clinic
- Private patient rooms with individual bathrooms and access to natural light
- Treatments are delivered every eight weeks
- Receive a SPECT/CT scan 24 hours after each treatment with a same-day follow-up appointment to discuss the results
- Continued collaboration between BAMF and your healthcare teams
- Continued collaboration between care teams
- Follow-up appointments as needed for imaging and treatment
- Access to advanced clinical trials
- You’ll always be part of the BAMF family!
Our Latest News
The University of Kansas Health System, University of Kansas Medical Center, Children’s Mercy, and BAMF Health to Develop Fully Integrated Destination Theranostic Research and Treatment Center
The University of Kansas Health System, the University of Kansas Medical Center, Children’s Mercy and BAMF Health announced intentions to establish one of the nation’s first fully integrated Theranostics platforms for both adult and pediatric patients.
February 17, 2026
World Traveler Becomes First-in-World Patient
Bill was the first patient in the world to participate in a clinical trial exploring an experimental radiopharmaceutical therapy for prostate cancer.
January 26, 2026
BAMF Health and Henry Ford Health Partner to Establish Comprehensive Theranostics Center in Detroit
The strategic partnership expands access to precision medicine, molecular imaging, and radiopharmaceutical therapy.
January 8, 2026